Home LiteratureArticle Details
PMID: 7883988 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy.

The Journal of clinical investigation ·Vol. 95 ·No. 3 ·1995-03-00 ·Pages 1409-14

Lankford EB, Epstein ND, Fananapazir L, Sweeney HL

Abstract

Missense mutations in the beta-myosin heavy chain (beta-MHC) gene cause hypertrophic cardiomyopathy (HCM). As normal and mutant beta-MHCs are expressed in slow-twitch skeletal muscle of HCM patients, we compared the contractile properties of single slow-twitch muscle fibers from patients with three distinct beta-MHC gene mutations and normal controls. Fibers with the 741Gly-->Arg mutation (near the binding site of essential light chain) demonstrated decreased maximum velocity of shortening (39% of normal) and decreased isometric force generation (42% of normal). Fibers with the 403Arg-->Gln mutation (at the actin interface of myosin) showed lowered force/stiffness ratio (56% of normal) and depressed velocity of shortening (50% of normal). Both the 741Gly-->Arg and 403Arg-->Gln mutation-containing fibers displayed abnormal force-velocity relationships and reduced power output. Fibers with the 256Gly-->Glu mutation (end of ATP-binding pocket) had contractile properties that were indistinguishable from normal. Thus there is variability in the nature and extent of functional impairments in skeletal fibers containing different beta-MHC gene mutations, which may correlate with the severity and penetrance of the disease that results from each mutation. These functional alterations likely constitute the primary stimulus for the cardiac hypertrophy that is characteristic of this disease.

MeSH Terms
Biopsy Cardiomyopathy, Hypertrophic/genetics,physiopathology Contractile Proteins/analysis Humans Isometric Contraction/physiology Muscle Fibers, Slow-Twitch/cytology,physiology Muscle, Skeletal/physiology Mutation Myosins/genetics
Chemicals
Contractile Proteins Myosins
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lankford E B
Cardiovascular Section, Hospital of the University of Pennsylvania, Philadelphia 19104-4283.
Epstein N D
Fananapazir L
Sweeney H L
References (27)
27 references, click to expand
  1. Hypertrophic cardiomyopathy: a discussion of nomenclature.
    Am J Cardiol. 1979 Jun;43(6):1242-4 PMID: 571671
  2. Three-dimensional structure of myosin subfragment-1: a molecular motor.
    Science. 1993 Jul 2;261(5117):50-8 PMID: 8316857
  3. Chemically skinned mammalian skeletal muscle. I. The structure of skinned rabbit psoas.
    Tissue Cell. 1979;11(3):553-66 PMID: 494240
  4. Structure of the actin-myosin complex and its implications for muscle contraction.
    Science. 1993 Jul 2;261(5117):58-65 PMID: 8316858
  5. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2.
    Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6270-4 PMID: 8327508
  6. Myocardial ischemia detected by thallium scintigraphy is frequently related to cardiac arrest and syncope in young patients with hypertrophic cardiomyopathy.
    J Am Coll Cardiol. 1993 Sep;22(3):796-804 PMID: 8102625
  7. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11.
    Nat Genet. 1993 Jul;4(3):311-3 PMID: 8358441
  8. Skeletal muscle myosin light chains are essential for physiological speeds of shortening.
    Nature. 1993 Sep 30;365(6445):454-6 PMID: 8413589
  9. Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.
    Circulation. 1994 Jan;89(1):22-32 PMID: 8281650
  10. Prognostic implications of novel beta cardiac myosin heavy chain gene mutations that cause familial hypertrophic cardiomyopathy.
    J Clin Invest. 1994 Jan;93(1):280-5 PMID: 8282798
  11. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere.
    Cell. 1994 Jun 3;77(5):701-12 PMID: 8205619
  12. Regional heterogeneity of function in hypertrophic cardiomyopathy.
    Circulation. 1994 Jul;90(1):186-94 PMID: 8025995
  13. The relation between stiffness and filament overlap in stimulated frog muscle fibres.
    J Physiol. 1981 Feb;311:219-49 PMID: 6973625
  14. Technique for stabilizing the striation pattern in maximally calcium-activated skinned rabbit psoas fibers.
    Biophys J. 1983 Jan;41(1):99-102 PMID: 6824759
  15. Myosin phosphorylation in permeabilized rabbit psoas fibers.
    Am J Physiol. 1985 Sep;249(3 Pt 1):C362-5 PMID: 4037077
  16. Electrophoretic separation and immunological identification of type 2X myosin heavy chain in rat skeletal muscle.
    Biochim Biophys Acta. 1990 Jul 20;1035(1):109-12 PMID: 2383576
  17. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.
    Cell. 1990 Sep 7;62(5):999-1006 PMID: 1975517
  18. Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy.
    Circulation. 1992 Feb;85(2):635-47 PMID: 1735158
  19. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.
    N Engl J Med. 1992 Apr 23;326(17):1108-14 PMID: 1552912
  20. Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families.
    Circ Res. 1992 Jul;71(1):3-8 PMID: 1606666
  21. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
    Circulation. 1992 Aug;86(2):345-52 PMID: 1638703
  22. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings.
    Circulation. 1992 Sep;86(3):730-40 PMID: 1516184
  23. Novel missense mutation in cardiac beta myosin heavy chain gene found in a Japanese patient with hypertrophic cardiomyopathy.
    Biochem Biophys Res Commun. 1992 Oct 15;188(1):379-87 PMID: 1417858
  24. Hypertrophic cardiomyopathy mutation is expressed in messenger RNA of skeletal as well as cardiac muscle.
    Circulation. 1993 Feb;87(2):406-12 PMID: 8425289
  25. Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
    Proc Natl Acad Sci U S A. 1993 May 1;90(9):3993-7 PMID: 8483915
  26. Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
    J Clin Invest. 1993 Jun;91(6):2861-5 PMID: 8514894
  27. The velocity of unloaded shortening and its relation to sarcomere length and isometric force in vertebrate muscle fibres.
    J Physiol. 1979 Jun;291:143-59 PMID: 314510
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1995-03-00
Pages
1409-14
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC441484
Subset
IM
Grants
NHLBI NIH HHS · HL-15835 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com